BioMed Research International / 2014 / Article / Tab 3

Research Article

Manufacturing Economics of Plant-Made Biologics: Case Studies in Therapeutic and Industrial Enzymes

Table 3

rBuChE facility cost summary (in millions of US dollars).

Plant growthAgrobacterium inoculum growth/infiltration/incubationRecovery/purificationTotals

Total capital investment$16.1$19.6$56.7$92.4
Annual operating costs excluding facility dependent costs$2.8$0.89$10.9$14.6
Annual operating costs including facility dependent costs$4.3$4.5$20.7$29.5

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.